DOCMORRIS AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 85.55 CHF | +3.63% |
|
+4.58% | +16.00% |
| Apr. 23 | DOCMORRIS : Deutsche Bank remains its Buy rating | ZD |
| Apr. 19 | DOCMORRIS : Hauck & Aufhauser gives a Buy rating | ZD |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 928.7 | 2,708 | 2,412 | 320.6 | 867.3 | 1,006 | - | - |
| Enterprise Value (EV) 1 | 1,036 | 2,978 | 2,714 | 723.2 | 1,144 | 1,253 | 1,287 | 1,314 |
| P/E ratio | -17.7 x | -18.9 x | -10.1 x | -1.61 x | 10.5 x | -12.6 x | -55.2 x | 50.9 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 0.69 x | 1.83 x | 1.4 x | 0.2 x | 0.9 x | 0.85 x | 0.63 x | 0.51 x |
| EV / Revenue | 0.76 x | 2.02 x | 1.57 x | 0.45 x | 1.18 x | 1.06 x | 0.8 x | 0.66 x |
| EV / EBITDA | -75.1 x | -38 x | -19 x | -9.31 x | -29.8 x | -59.4 x | 35.8 x | 17.7 x |
| EV / FCF | -4.59 x | -23.4 x | -14 x | -3.87 x | -9.94 x | -18.9 x | -28.7 x | 557 x |
| FCF Yield | -21.8% | -4.27% | -7.15% | -25.9% | -10.1% | -5.3% | -3.48% | 0.18% |
| Price to Book | 1.67 x | 5.09 x | 5.44 x | 0.84 x | 2.01 x | 2.53 x | 2.58 x | 2.6 x |
| Nbr of stocks (in thousands) | 8,680 | 9,568 | 10,240 | 12,543 | 11,760 | 11,762 | - | - |
| Reference price 2 | 107.0 | 283.0 | 235.5 | 25.56 | 73.75 | 85.55 | 85.55 | 85.55 |
| Announcement Date | 3/19/20 | 3/18/21 | 3/24/22 | 3/24/23 | 3/20/24 | - | - | - |
1CHF in Million2CHF
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,356 | 1,477 | 1,726 | 1,608 | 966.9 | 1,183 | 1,607 | 1,990 |
| EBITDA 1 | -13.8 | -78.4 | -142.6 | -77.7 | -38.4 | -21.1 | 35.89 | 74.25 |
| EBIT 1 | -45.7 | -117.6 | -193.8 | -140.3 | -83.2 | -64.5 | -7.648 | 35 |
| Operating Margin | -3.37% | -7.96% | -11.23% | -8.72% | -8.6% | -5.45% | -0.48% | 1.76% |
| Earnings before Tax (EBT) 1 | -50.1 | -133.2 | -226.7 | -169.9 | -118.7 | -85.06 | -34.8 | 11.09 |
| Net income 1 | -52.4 | -135.6 | -225.7 | -171.1 | 82.2 | -84.01 | -20.48 | 20.45 |
| Net margin | -3.87% | -9.18% | -13.07% | -10.64% | 8.5% | -7.1% | -1.27% | 1.03% |
| EPS 2 | -6.040 | -14.95 | -23.40 | -15.88 | 7.050 | -6.796 | -1.551 | 1.679 |
| Free Cash Flow 1 | -225.8 | -127.3 | -194.1 | -187.1 | -115.1 | -66.42 | -44.77 | 2.36 |
| FCF margin | -16.65% | -8.62% | -11.24% | -11.63% | -11.91% | -5.61% | -2.79% | 0.12% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | 3.18% |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | 11.54% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 3/19/20 | 3/18/21 | 3/24/22 | 3/24/23 | 3/20/24 | - | - | - |
1CHF in Million2CHF
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 Q3 | 2021 Q4 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 S2 | 2024 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 687.1 | 698 | 778.9 | 839.8 | 443.4 | 443.4 | 886.7 | 418.9 | 405.1 | 824 | 784.2 | 402.8 | 235.5 | 463 | 503.9 | 265 |
| EBITDA | -11.34 | -24.45 | -53.95 | -49.71 | - | - | -92.89 | - | - | -43.08 | -34.62 | - | - | -28.1 | - | - |
| EBIT | - | - | - | -73.11 | - | - | -120.7 | - | - | -69.45 | -70.85 | - | - | -48.8 | - | - |
| Operating Margin | - | - | - | -8.71% | - | - | -13.61% | - | - | -8.43% | -9.03% | - | - | -10.54% | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - | -83.04 | - | - | - | - | - |
| Net income | - | - | - | - | - | - | -148.7 | - | - | -86.09 | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | -16.77% | - | - | -10.45% | - | - | - | - | - | - |
| EPS | - | - | - | -8.030 | - | - | - | - | - | -8.290 | -7.590 | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 3/19/20 | 8/19/20 | 3/18/21 | 8/18/21 | 12/24/21 | 3/24/22 | 3/24/22 | 5/18/22 | 8/18/22 | 8/18/22 | 3/24/23 | 5/17/23 | 8/17/23 | 8/17/23 | 3/20/24 | - |
1CHF in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 107 | 270 | 303 | 403 | 277 | 247 | 280 | 308 |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -7.768 x | -3.444 x | -2.123 x | -5.181 x | -7.208 x | -11.69 x | 7.813 x | 4.145 x |
| Free Cash Flow 1 | -226 | -127 | -194 | -187 | -115 | -66.4 | -44.8 | 2.36 |
| ROE (net income / shareholders' equity) | -12.3% | -28.9% | -44.4% | -39% | -29.2% | -19.4% | -8.25% | 0.51% |
| ROA (Net income/ Total Assets) | -6.09% | -11.9% | -17.7% | -13.8% | -11.6% | -7.38% | -1.77% | 2.89% |
| Assets 1 | 859.8 | 1,135 | 1,274 | 1,242 | -708 | 1,139 | 1,154 | 708.1 |
| Book Value Per Share 2 | 63.90 | 55.60 | 43.30 | 30.40 | 36.60 | 33.80 | 33.20 | 32.90 |
| Cash Flow per Share 2 | -9.530 | -7.440 | -13.00 | -9.030 | -7.490 | -3.310 | -0 | 3.930 |
| Capex 1 | 10.4 | 59.8 | 63.5 | 59.3 | 27.7 | 32.5 | 34.5 | 38.6 |
| Capex / Sales | 0.77% | 4.05% | 3.68% | 3.69% | 2.87% | 2.75% | 2.15% | 1.94% |
| Announcement Date | 3/19/20 | 3/18/21 | 3/24/22 | 3/24/23 | 3/20/24 | - | - | - |
1CHF in Million2CHF
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
85.55
CHF
Average target price
99.24
CHF
Spread / Average Target
+16.00%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +16.00% | 1.1B | |
| -31.97% | 10.84B | |
| +8.14% | 6.04B | |
| -11.41% | 5.86B | |
| -30.42% | 6.06B | |
| -0.88% | 4.71B | |
| +52.19% | 4.29B | |
| -12.31% | 3.61B | |
| -14.86% | 3.33B | |
| -6.93% | 3.01B |
- Stock Market
- Equities
- ROSE Stock
- Financials DocMorris AG
